Genetic variation and common diseases. Where are we? Where to go?

F. Demenais (Paris, France)

Source: Research Seminar 2009 - Post Genome Respiratory Epidemiology II - An interdisciplinary challenge

Number: 5

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Demenais (Paris, France). Genetic variation and common diseases. Where are we? Where to go?. Research Seminar 2009 - Post Genome Respiratory Epidemiology II - An interdisciplinary challenge

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Clustering in asthma: why, how and for how long? Source: Eur Respir J 2013; 41: 1247-1248 Year: 2013
Genotype, phenotype and the environment in respiratory diseases: what contributes the most? Source: Annual Congress 2012 - Genetics and genomics in asthma and COPD: prediction and personalised medicine Year: 2012
Does “UIPAF” really exist? Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020
Rare pulmonary diseases and orphan drugs: where do we stand and where are we going to? Source: Eur Respir Rev 2015; 24: 375-377 Year: 2015
Respiratory disease in the community. Who‘s got what? Source: Annual Congress 2009 - Diagnostic strategies in primary respiratory care Year: 2009
Why don't patients follow the rules? Understanding the motivation behind behavioural change Source: Annual Congress 2013 –PG8 How to encourage compliance with therapy Year: 2013
Respiratory diseases across generations. Is there a common denominator? Source: ERS Research Seminar 2016 Year: 2016
Positional therapy: who, when and how? Source: Sleep and Breathing Conference 2021 Year: 2021
What’s new in the epidemiology of asthma? Source: Virtual Congress 2021 – Paediatric year in review Year: 2021
Infections in children: is there an underlying rare disease? Source: International Congress 2019 – Part I: Prevention and management of respiratory infections in primary care. Year: 2019
Treatment of early lung disease – is it possible? Does it work? Source: Annual Congress 2004 - PG19 - Screening for cystic fibrosis: diagnose early - treat early Year: 2004
COVID-19 phenotypes: leading or misleading? Source: Eur Respir J, 56 (2) 2002195; 10.1183/13993003.02195-2020 Year: 2020
Monitoring of early lung disease. To know is to treat! Source: Annual Congress 2004 - PG19 - Screening for cystic fibrosis: diagnose early - treat early Year: 2004
Do allergic diseases and symptoms show the same pattern of genetic and environmental influences? Source: Eur Respir J 2002; 20: Suppl. 38, 119s Year: 2002
Cleaning agents and asthma: what does the epidemiology really tell us? Source: International Congress 2018 – Cleaning agent exposures: are they really harmful to lung health? Year: 2018
To tracheostomize or not to tracheostomize? Source: Eur Respir J 2005; 26: Suppl. 49, 393s Year: 2005
Just correlations? Unravelling the origins of the asthma epidemic Source: Annual Congress 2008 - Sadoul Lecture Year: 2008
Is asthma a risk factor for COVID-19? Are phenotypes important? Source: ERJ Open Res, 7 (1) 00216-2020; 10.1183/23120541.00216-2020 Year: 2021